Sign In
Buy RBGLY
$14.05
-0.300 (-2.09%)
At Close: Jul 31, 2026
Reckitt Benckiser results 'good enough' but not out of the woods yet
10:42am, Wednesday, 23'rd Oct 2024
Shares in Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) rose almost 4% to a six-month high after the Cilit Bang, Nurofen and Durex maker reported a smaller fall in sales than investors feared. Thir
Reckitt Benckiser posts drop in revenue as nutrition wing weighs
02:54am, Wednesday, 23'rd Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has said sales fell over the third quarter as revenue from its nutrition wing slumped. Like for like revenue declined by 0.5% to £3,46 billion during th
Healthcare helps Reckitt beat quarterly sales estimates
02:13am, Wednesday, 23'rd Oct 2024
Reckitt reported a smaller than expected fall in third-quarter underlying sales on Wednesday, helped by its health business, which makes Nurofen painkillers and Strepsils lozenges.
Reckitt promotional push threatens sales as earnings loom
06:34am, Thursday, 17'th Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) will offer up third-quarter results next Wednesday, 23 October reflecting what analysts believe will have seen a drop in sales. Barclays analysts forecas
RBGLY vs. CLX: Which Stock Is the Better Value Option?
12:46pm, Monday, 07'th Oct 2024
Investors looking for stocks in the Soap and Cleaning Materials sector might want to consider either Reckitt Benckiser Group PLC (RBGLY) or Clorox (CLX). But which of these two stocks is more attracti
Reckitt Benckiser could return £12.5bn after overhaul, says leading investment bank
06:46am, Friday, 04'th Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) could return up to £12.5 billion to shareholders, about 40% of its market value, as part of a major strategic overhaul, according to Barclays. The compa
Reckitt Benckiser has sales and legal risks aplenty as third-quarter results approach
10:22am, Wednesday, 02'nd Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is facing multiple challenges ahead of its third-quarter results, with Jefferies forecasting a -1% drop in like-for-like sales. Key reasons for the limp
Abbott, Reckitt face trial over premature baby formula amid alarm from doctors
08:03am, Monday, 30'th Sep 2024
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott , Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she
Reckitt in talks to sell £6bn homecare portfolio, reports Bloomberg
07:47am, Wednesday, 18'th Sep 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is in talks with interested parties to dispose of its £6 billion homecare portfolio, which includes household brands Air Wick, Mortein, Calgon and Cilli
Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports
01:41pm, Tuesday, 17'th Sep 2024
Reckitt Benckiser has initiated early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesd
10 High-Yield A-Rated Blue-Chips For Potentially Scary Times Ahead
07:00am, Friday, 30'th Aug 2024
The economy is stable but cooling, with the labor market showing signs of slowing down. GDP growth is likely to keep falling, and individual companies could suffer. Long-term investors should focus on
Haleon, Reckitt, Wizz Air: Stocks lifting despite global sell-off
10:16am, Monday, 05'th Aug 2024
While the FTSE 100 continues to suffer its worst session in recent times, dropping 2.5%, there are a handful of companies which have been able to buck the bearish trend. Out of London's blue chips,
Abbott Labs Stock Falls After Baby-Formula Ruling. Reckitt Benckiser Tumbles Too.
06:13am, Monday, 29'th Jul 2024
Shares of Abbott Laboratories and U.K.-listed Reckitt Benckiser both drop after a Missouri jury rules against the American healthcare company.
Baby-formula settlement drags Reckitt down after $495 million jury award against Abbott
03:37am, Monday, 29'th Jul 2024
U.K. consumer-products giant Reckitt saw its share price slump after a jury awarded $495 million in a key baby-formula case.
Reckitt Benckiser shares whacked by US infant formula litigation read-across
03:33am, Monday, 29'th Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares tumbled 7.5% on Monday morning after a litigation decision in the US against Abbott Laboratories (NYSE:ABT) on Friday, where investors are readin
